Canada · Who invested in LymphoSign?
LymphoSign's investors include VenGrowth and GeneChem.
Canada · Series A startup
Who invested in LymphoSign
Funding summaryUpdated 26 Oct 2026
$5.9Mraised across 1 round since 2003, from 1 source
- Latest round
- Series A, $5.9MJul 2003
- Investors
- 2
The rounds
- Jul 2003
The exit
ExitBuyerPriceWhen
AcquiredAegera TherapeuticsundisclosedAug 2007
From historical deal records. Wrong? Tell us.
Quick answers about LymphoSign
How much has LymphoSign raised?
LymphoSign has raised $5.9M across 1 round since 2003.
When did LymphoSign last raise?
LymphoSign's most recent round was a Series A of $5.9M in Jul 2003.
What was LymphoSign's biggest round?
Its most recent round, $5.9M in Jul 2003, is also its largest on record.
Who backed LymphoSign first?
LymphoSign's first round on record, in Jul 2003, was backed by VenGrowth and GeneChem.
What stage is LymphoSign at?
LymphoSign's latest named round is a Series A, in Jul 2003.
Where is LymphoSign based?
LymphoSign is based in Canada.
Companies like LymphoSign
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.